Trials / Recruiting
RecruitingNCT06439901
Optimizing Bronchopulmonary Cancer Screening
Optimizing the Implementation of Bronchopulmonary Cancer Screening in the Ile de France Region (OPTI-DEPIST-MUT)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- Institut Curie · Academic / Other
- Sex
- All
- Age
- 50 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the feasibility of performing a first screening for bronchopulmonary cancer by thoracic scanner in a French cohort within a dedicated, effective and structured network in the pilot centers participating in the study.
Detailed description
The organization of bronchopulmonary cancer screening in the Ile de France region, within the Mutualists and its affiliated health centers, is based on a clear, simple and functional process: * Definition of eligibility criteria for screening, based on those of the NELSON study, * Referral and consultation by a health center physician trained in these criteria, * Referral and performance of a chest Computer Tomography Scanner (CTscan) according to the same recommendations, * Structured centralized reading and interpretation of CTscan images, * Referral to a multidisciplinary team (CITT), if bronchopulmonary cancer is suspected, * Referral to a tobacco unit in a health center for smokers who have not stopped smoking, * Organization of follow-up and continuation of the screening program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Screening | A first step to identify and recruit people eligible for screening, |
| OTHER | Inclusion | A second step for inclusion of participants, with an online self-questionnaire and information, and an inclusion visit to the health center, |
| OTHER | Chest CTscan and follow-up | A third step with an initial CTscan, with dual interpretation and appropriate management of participants, including follow-up care. |
Timeline
- Start date
- 2025-01-17
- Primary completion
- 2032-01-17
- Completion
- 2033-01-17
- First posted
- 2024-06-03
- Last updated
- 2025-02-03
Locations
8 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06439901. Inclusion in this directory is not an endorsement.